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Background: LMNA/C mutations have been linked to the premature aging syndrome Hutchinson’s progeria, dilated
cardiomyopathy 1A, skeletal myopathies (such as the autosomal dominant variant of Emery-Dreifuss muscular
dystrophy and limb-girdle muscular dystrophy), Charcot-Marie-Tooth disorder type 2B1, mandibuloacral dysplasia,
autosomal dominant partial lipodystrophy, and axonal neuropathy. Atrioventricular block (AVB) can be associated
with several cardiac disorders and it can also be a highly heritable, primitive disease.
One of the most common pathologies associated with AVB is dilated cardiomyopathy (DCM), which is
characterized by cardiac dilatation and reduced systolic function. In this case, onset has been correlated with
several mutations in genes essential for the proper maturation of cardiomyocytes, such as the gene for lamin A/C.
However, no clear genotype–phenotype relationship has been reported to date between LMNA/C mutations and
cardiomyopathies.
Results: DNA and medical histories were collected from (n = 11) members of different generations of one family,
the proband of which was implanted with a pacemaker for lone, type II AVB. Exome sequencing analysis was
performed on three relatives with AVB, and the mutations therein identified validated in a further three
AVB-affected family members.
In the initial three AVB family members, we identified 10 shared nonsynonymous single-nucleotide variations with
a rare or unreported allele frequency in the 1000 Genomes Project database. Follow-up genetic screening in the
additional three affected relatives disclosed a correlation between the lone AVB phenotype and the single-nucleotide
polymorphism rs56816490, which generates an E317K change in lamin A/C. Although this mutation has already
been described by others in a DCM-affected proband with familiarity for AVB and sudden death, the absence of
DCM in our large, AVB-affected family is indicative of genotype–phenotype correlation between rs56816490 and a
familial, autosomal dominant form of lone AVB.
Conclusions: Screening for G613A in LMNA/C in patients with lone AVB and their relatives might prevent sudden
death in families affected by AVB but without familiarity for DCM. Lone AVB is an age-related disease caused by
mutations in LMNA/C gene rather than a complication of DCM.
Keywords: Arrhythmia, Dilated cardiomyopathy, Exome sequencing, Atrioventricular block, Lamin A/C* Correspondence: apuca@unisa.it
2IRCCS Multimedica, Milan, Italy
9Dipartimento di Medicina e Chirurgia, Università degli Studi di Salerno, Via
Giovanni Paolo II, 132, 84084, Fisciano, Salerno, Italy
Full list of author information is available at the end of the article
© 2014 Villa et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Villa et al. Immunity & Ageing 2014, 11:19 Page 2 of 6
http://www.immunityageing.com/content/11/1/19Background
Atrioventricular block (AVB) is a partial or complete
block in the transmission of the electrical impulses ori-
ginating in the atrium or sinus node and directed toward
the AV node and ventricles. Depending on the gravity of
AVB, cases are grouped into one of three different
categories: type I AVB is characterized by prolongation
of AV conduction time; type II AVB is characterized by
failed transmission of some impulses, with consequent
loss of some ventricular contractions; and type III AVB
is characterized by complete AV dissociation and loss
of many/all contractions or coordination with atrial
contraction [1].
AVB can be associated with several cardiac disorders,
such as dilated cardiomyopathy (DCM), ischemia, infarc-
tion, and fibrosis, and may present as an aggravation of
existing cardiac suffering. AVB can also be caused by a
highly heritable, primitive disease presenting itself at an
early age [2]. Little is known about the origin of progres-
sive cardiac conduction defects, such as congenital AVB,
although linkage analyses of affected families of different
nationalities has led to the identification of several causal
mutations in sodium-channel, melastatin-4, and NK2
homeobox 5 genes, [3-5] and to the identification of a
disease-related locus at chr1q32.2-q32.3 [6].
One of the most common pathologies associated with
AVB is DCM, which is characterized by cardiac dilata-
tion and reduced systolic function. In this case, onset
has been correlated with several mutations in genes essen-
tial for the proper maturation of cardiomyocytes. For ex-
ample, autosomal dominant DCM and conduction system
diseases are linked to a disease locus at chr1p1-q21, where
the gene for lamin A/C (LMNA/C) is encoded [7]. The
coding region of LMNA/C spans approximately 24 kb, har-
bors 12 exons, and produces the alternative splice products
LMNA (74 kDa) and LMNC (65 kDa) [8]. Lamins have an
essential role in maintaining nuclear shape and structure,
transcriptional regulation, nuclear pore function, and het-
erochromatin organization [9]. In patients with DCM
associated with AVB and carriers of LMNA/C mutations,
reduced LMNA/C expression caused damage to cardio-
myocyte nuclei and nuclear membranes, such as focal dis-
ruptions, bleb formations, and nuclear pore clustering [10].
Apart from dilated cardiomyopathy 1A, LMNA/C muta-
tions have also been linked to the premature aging syn-
drome Hutchinson’s progeria, skeletal myopathies (such
as the autosomal dominant variant of Emery-Dreifuss
muscular dystrophy and limb-girdle muscular dystrophy),
Charcot-Marie-Tooth disorder type 2B1, mandibuloacral
dysplasia, autosomal dominant partial lipodystrophy, and
axonal neuropathy [9,11]. However, no clear genotype–
phenotype relationship has been reported to date between
LMNA/C mutations and cardiomyopathies [12]. There-
fore, we decided to identify causative mutation(s) throughexome sequencing of a family with an autosomal domin-
ant form of AVB.
Results and discussion
A large family from central Italy was recruited for the
genetic study of a familial autosomal dominant form of
lone, type II AVB. The pedigree was composed of 31
subjects belonging to five different generations, 10 of
which presenting with the pathology. Six affected and
five apparently unaffected members participated in the
study (Figure 1). The criterion for AVB diagnosis was
the presence of AV node block at either standard ECHO
or 24-hour Holter recording, or the presence of an im-
planted pacemaker.
Electrophysiological study of the proband revealed a
long AV-node refractory period of 420 msec at a cycle
length of 600 msec, and 2:1 AV block at a cycle length
of 450 msec. ECHO did not indicate the presence of
DCM in the proband (see online Additional file 1), and
there were no indications of DCM in the medical his-
tories of any of the other affected family members,
some of which had received a pacemaker (a summary
of the subjects with known cardiovascular dysfunction
is provided in Table 1). There was no significant infor-
mation on predisposing life styles and risk factors for
AVB in these subjects.
The exceptional longevity of some ancestors (95 years
for II:1 and 98 years for II:5) and the reported [13] delay
in the onset of age-associated diseases, including AVB,
in long-living offspring induced us to run a study on
only affected members, so as to avoid possible misclassi-
fication of affected status of the analyzed subjects [13].
To identify the causative gene mutation(s), we se-
quenced the whole exome of three affected members of
the family: one fourth-generation member (IV:4, the pro-
band) and two third-generation subjects (III:5 and III:8).
Filtered results indicated that 10 nonsynonymous and
damaging mutations were common to the three subjects
(Table 2). We then checked the presence of these muta-
tions in three other affected family members (III:1, III:3,
and III:9): out of the 10 mutations assessed, G613A in
LMN A/C (rs56816490) was carried in a heterozygous
fashion by all affected individuals (Figure 2). Analysis for
the presence of rs56816490 in non-affected family mem-
bers and in 100 control subjects, in agreement with the
1000 Genomes Project, [14] was negative (Figure 3).
LMNA/C variations are responsible for many different
diseases involving, above all, muscle tissue, including DCM
with conduction defects [14]. However, to date there is no
clear genotype–phenotype correlation between LMNA/C
mutations and DCM associated with conduction distur-
bances. In the present study, we correlate the missense
mutation G613A in LMNA/C (SNP ID rs56816490) with a
familial, autosomal dominant form of AVB that we classify
Figure 1 Pedigree of the studied atrioventricular block family. Generation is indicated with roman numerals, and individual ID is indicated
with Arabic numerals. Solid squares (males) and circles (females) indicate affected subjects, open symbols indicate unaffected subjects, and gray
symbols indicate unknown disease status. Diamonds indicate not-relevant subjects, and the numbers within them are the number of subjects.
Diagonal lines indicate dead subjects. Arrows identify the analyzed subjects. M indicates the subjects carrying rs56816490. PM indicates pacemaker
implantation. The proband is indicated with a red oval. Ages of subject are given beneath the individual’s ID number.
Table 1 Known medical histories of subjects in the
pedigree
Generation Subject ID Age Gender Medical history
II 2 95 Female Two pacemakers
II 5 98 Female Pacemaker
II 7a 72 Male Sudden death
II 7b 70 Male Asthma
III 1 50 Female Pacemaker
III 3 65 Female Pacemaker
III 4 75 Male Pacemaker
III 5 73 Female Pacemaker
III 8 72 Male Pacemaker
III 9 79 Female Pacemaker
III 11a 66 Male Sudden death
III 11b 75 Male Sudden death
III 11c 71 Female Small cardiac suffering
IV 4 59 Female Pacemaker, atrial fibrillation
V 1 16 Male Pacemaker
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medical history and on the absence of any abnormality in
ventricular and atrial sizes in the proband. The SNP is lo-
cated within the 6th exon of LMNA/C, which is located at
chr1:156205704, and determines the amino acid change
E317K in a segment of the LMNA/C coil 2 that does not
interact with proteins or chromatin.
Arbustini et al. [15] have already described this muta-
tion in a proband with AVB putatively associated with a
late-onset DCM: the patient was suffering from AVB
since age 44 years, had a family history of sudden death,
and was implanted with pacemaker at age 69 years. The
proband’s father, also a pacemaker carrier, received a
post-mortem diagnosis of DCM, indicating that the son’s
clinical status may worsen sometime in the future due to
DCM, although this has not been documented to date
[15]. Careful analysis of the mutations detected in DCM
patients with conduction defects led Arbustini et al. [15]
to conclude that clinical manifestations and disease evo-
lution were more severe in patients with LMNA/C mu-
tations that affected nuclear lamin interactions, whereas
the E317K change, present in a non-interacting segment,
was responsible for a mild phenotype.
Table 2 Stop gain/nonsynonymous SNPs identified by exome sequencing
Variant coordinates SNP ID Gene Function Nucleotide changes MAF* (%)
chr1:111784045 - CHI3L2 Nonsynonymous G-- > A
chr1:113162494 rs41283062 CAPZA1 Nonsynonymous G-- > A 1.380
chr1:114367793 rs140698521 PTPN22 Nonsynonymous C-- > T 0.064
chr1:156105704 rs56816490 LMNA Nonsynonymous G-- > A
chr4:2744193 - TNIP2 Nonsynonymous A-- > G
chr5:63802483 - RGS7BP Nonsynonymous G-- > C
chr10:11374607 - CELF2 - T-- > A
chr11:104768141 rs138698464 CASP12 Nonsynonymous G-- > A 1.335
chr21:34924550 rs142482063 SON Nonsynonymous G-- > T 0.044
chr22:19511925 rs885985 CLDN5 Stop gain G-- > A 44.631
*,UCSC Genome Browser database. MAF =Minor allele frequency.
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status of the LMNA/C E317K-carrying proband described
by Arbustini et al. as affected with lone AVB. Of note,
E317K is a rare change in LMNA/C, and both families
were from Italy; thus, we cannot exclude a common origin
of the mutation.
Conclusions
Our results are important for genetic counselling,
pointing to the need for screening G613A in LMNA/CFigure 2 Electropherogram of the lamin A/C gene. Electropherograms
showing heterozygosity for the LMNA/C mutation G613A in the latter. Hete
G and A (arrow and magnification).in patients with lone AVB and their relatives. Indeed, in
the family we investigated, three subjects (one in gener-
ation II, and two in generation III) had a medical
history of sudden death, as did the E317K LMNA/C
carriers reported by Arbustini et al. [15]. Furthermore,
our data point to lone AVB as a disease caused by mu-
tation of LMNA/C inducing accelerated aging, and thus
makes appealing the hypothesis that AVB is an age-
related disease on its own right, other than a complica-
tion of DCM.of control (upper) and atrioventricular block-affected (lower) subjects
rozygosity is indicated by the presence of two peaks corresponding to
Figure 3 Frequency analysis of controls with PCR for rs56816490. Image of electrophoretic analysis of PCR validation amplifications of
genomic DNA from pedigree subjects (III:2 and IV:4) and independent controls. Amplification of the mutated allele of LMNA/C (G613A) is present
only in the affected subject (IV:4, the proband).
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The study was conducted in accordance with the ethical
principles that have their origins in the Declaration of
Helsinki. Informed consent was obtained from all sub-
jects in accordance with the Review Board rules of
IRCCS Multimedica. Subjects were evaluated, when pos-
sible, by medical history, physical examination, and elec-
trocardiography. Reports from echocardiography (ECHO),
cardiac catheterization, electrophysiology studies, cardiac
surgery, and/or autopsy were reviewed when available.
Clinical assessment was performed without knowledge
of genotype.
DNA isolation and exome sequencing
Genomic DNA was isolated from whole blood, using the
QIAamp DNA Blood Midikit (Qiagen), according to the
manufacturer’s protocol. Exonic regions of genomic DNA
of three affected subjects (IDs III:5, III:8, and IV:4) were
enriched using either the TruSeq™ Exome Enrichment Kit
(Illumina) or the Agilent Haloplex Exome kit based on
DNA digestion and capture. Exomes were barcoded and
sequenced at multiple sites on the Illumina HiSeq1000
platform, and either 2 × 76-bp (TruSeq) or 2 × 100-bp
(Haloplex) PE libraries, using TruSeq SBS Kit v3–HSTable 3 Primer sequences used in the validation analysis










CLDN5 CCATGGCTAGAGGCGAGAC(Illumina) reagents and a TruSeq PE Cluster kit v.3-cbot-
HS flow cell. Average coverage for all the experiments was
70x and at least 20x for 89% of the target. Paired se-
quencing reads were aligned to the reference genome
(UCSC, hg19 build) using BWA [16] and sorted with
SAMtools [17] and Picard (http://broadinstitute.github.io/
picard/). Post-alignment processing (local realignment
around insertions-deletions and base recalibration), SNV,
and small insertions-deletions (ins-del) calling were per-
formed with Genome Analysis Toolkit (GATK) [18] with
parameters adapted to the haloplex-generated sequences.
The called SNV and ins-del variants produced with both
platforms were annotated using ANNOVAR [19].Data filtering
The results were first filtered to eliminate common vari-
ants (MAF > 1%), variants with low quality score, and vari-
ants not shared by all analyzed affected subjects, when
covered. Additional frequency filters were used by com-
paring internal databases of whole exome sequencing data
(n = 300). Prioritization was also made based on MAF
frequency (complete data sets are available in online
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Genomic DNA of the remaining affected subjects was
amplified by standard polymerase chain reaction (PCR)
methods for selected single-nucleotide polymorphisms
(SNPs). The amplified fragments were purified with the
Wizard SV Gel and PCR Clean-Up System (Promega)
and were sequenced in order to identify the mutation as-
sociated with AVB. Primer sequences and PCR condi-
tions are given in Table 3.Mutation detection by PCR in controls
Two forward PCR primers were designed for the ampli-
fication of the rs56816490 locus in LMNA/C: a primer
targeting wild-type LMNA/C (5′-CAGCTGGCAGCCA
AGg-3′) and another primer targeting a mutated variant
(5′-CAGCTGGCAGCCAAGa-3′). Direct amplification
of genomic DNA of 100 controls was performed using
independently both the forward primer and the reverse
primer (5′-CGCATCTCGGCCATCTC-3′) followed by
visualization on an agarose gel with ethidium bromide
staining.Additional files
Additional file 1: Additional figure: cardiac assessment of the
Proband. Recent echocardiography and electrocardiography of the
proband.
Additional file 2: Complete data sets: the file lists the results of
exome sequencing analysis.Abbreviations
AVB: Atrioventricular block; DCM: Dilated cardiomyopathy;
ECHO: Echocardiogram; LMNA/C: Lamin A/C; PCR: Polymerase chain reaction;
SNP: Single-nucleotide polymorphism.
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